Canaccord analyst Richard Close downgraded Oak Street Health (OSH) to Hold from Buy with a price target of $39, up from $29, after CVS Health (CVS) announced a deal to acquire Oak Street for $39 per share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on OSH:
- CVS Health says Oak Street Health deal has long term growth, earnings power
- Oak Street Health downgraded to In Line from Outperform at Evercore ISI
- Oak Street Health downgraded to Neutral from Overweight at Piper Sandler
- Oak Street Health downgraded to Hold from Buy at Stifel
- CVS Finally Confirms OSH Deal; Beats Q4 Expectations